Randomized trials for the treatment of burning mouth syndrome: An evidence-based review of the literature

Journal of Oral Pathology and Medicine

Volumn 41, Issue 4, 2012, Pages 281-287

  De Moraes, Maiara ^a   Do Amaral Bezerra, Bruna Aguiar ^a   Da Rocha Neto, Pedro Carlos ^a   De Oliveira Soares, Ana Clara Azevedo ^a   Pinto, Leão Pereira ^a   De Lisboa Lopes Costa, Antonio ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

Author keywords

Burning mouth syndrome; Randomized controlled trials; Stomatodynia; Therapy

Indexed keywords

BENZYDAMINE; BETHANECHOL; CAPSAICIN; CLONAZEPAM; LACTOPEROXIDASE; PLACEBO; THIOCTIC ACID; TRAZODONE;

ABDOMINAL PAIN; ABSENCE OF SIDE EFFECTS; BLOOD PRESSURE; BURNING MOUTH SYNDROME; BURNING SENSATION; CLINICAL EFFECTIVENESS; COLD SWEAT; DIZZINESS; DROWSINESS; FOLLOW UP; HEARTBURN; HUMAN; HYPOTENSION; MEDLINE; NAUSEA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SHIVERING; SIDE EFFECT; STOMACH PAIN; THERAPY EFFECT; VISUAL ANALOG SCALE; XEROSTOMIA;

ANTIOXIDANTS; BURNING MOUTH SYNDROME; CAPSAICIN; CLONAZEPAM; EVIDENCE-BASED DENTISTRY; GABA MODULATORS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENSORY SYSTEM AGENTS; THIOCTIC ACID;

EID: 84858700426     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2011.01100.x     Document Type: Review

References (28)

1. Sardella A, Uglietti D, Demarosi F, Lodi G, Bez C, Carrassi A. Benzydamine hydrocloride oral rinses in management of burn mouth syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 88: 693-6.
2. Femiano F, Scully C. Burning mouth syndrome (BMS): double blind controlled study of alpha-lipoic acid (thioctic acid) therapy. J Oral Pathol Med 2002; 31: 267-9.
3. Patton LL, Siegel MA, Benoliel R, De Laat A. Management of burning mouth syndrome: systematic review and management recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103(Suppl 1): S39.
4. Scala A, Checchi L, Montevecchi M, Marini I, Giamberardino MA. Update on burning mouth syndrome: overview and patient management. Crit Rev Oral Biol Med 2003; 14: 275-91.
5. Minguez-Sanz M, Salort-Llorca C, Silvestre-Donat F. Etiology of burning mouth syndrome: a review and update. Med Oral Patol Oral Cir Bucal 2011; 16(2): 144-8.
6. López-Jornet P, Camacho-Alonso F, Leon-Espinosa S. Efficacy of alpha lipoic acid in burning mouth syndrome: a randomized, placebo-treatment study. J Oral Rehabil 2009; 36: 52-7.
7. Gremeau-Richard C, Woda A, Navez ML, et al. Topical clonazepam in stomatodynia: a randomised placelo-controlled study. Pain 2004; 108: 51-7.
8. Grémeau-Richard C, Dubray C, Aublet-Cuvelier B, Ughetto S, Woda A. Effect of lingual nerve block on burning mouth syndrome (stomatodynia): a randomized crossover trial. Pain 2010; 149: 27-32.
9. Marino R, Torretta S, Capaccio P, Pignataro L, Spadari F. Different therapeutic strategies for burning mouth syndrome: preliminary data. J Oral Pathol Med 2010; 39: 611-6.
10. Petruzzi M, Lauritano D, De Benedittis M, Baldoni M, Serpico R. Systemic capsaicin for burning mouth syndrome: short-term results of a pilot study. J Oral Pathol Med 2004; 33: 111-4.
11. Escosteguy CC. Tópicos metodológicos e estatísticos em ensaios clínicos controlados randomizados. Arq Bras Cardiol 1999; 72(2): 139-43.
12. Maina G, Vitalucci A, Gandolfo S, Bogetto F. Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study. J Clin Psychiatry 2002; 63(1): 38-43.
13. Heckmann SM, Hujoel P, Habiger S, et al. Zinc gluconate in the treatment of dysgeusia: a randomized clinical trial. J Dent Res 2005; 84: 35-8.
14. Carbone M, Pentenero M, Carrozzo M, Ippolito A, Gandolfo S. Lack of efficacy of alpha-lipoic acid in burning mouth syndrome: a double-blind, randomized, placebo-controlled study. Eur J Pain 2009; 13(5): 492-6.
15. Cavalcanti DR, Silveira FRX. Alpha lipoic acid in burning mouth syndrome - a randomized double-blind placebo-controlled trial. J Oral Pathol Med 2009; 38: 254-61.
16. Sardella A, Lodi G, Demarosi F, Tarozzi M, Canegallo L, Carrassi A. Hypericum perforatum extract in burning mouth syndrome: a randomized placebo-controlled study. J Oral Pathol Med 2008; 37: 395-401.
17. López-D'Alessandro E, Escovich L. Combination of alpha lipoic acid and gabapentin, its efficacy in the treatment of burning mouth syndrome: a randomized, double-blind, placebo controlled trial. Med Oral Patol Oral Cir Bucal 2011; 16(5): e635-40.
18. Femiano F. Burning mouth syndrome (BMS): an open trial of comparative efficacy of alpha-lipoic acid (thioctic acid) with other therapies. Minerva Stomatol 2002; 51(9): 405-9.
19. Tammiala-Salonen T, Forssell H. Trazodone in burning mouth pain: a placebo-controlled, double-blind study. J Orofac Pain 1999; 13(2): 83-8. "published data only".
20. Zakrzewska JM, Forssell H, Glenny AM. Interventions for the treatment of burning mouth syndrome. Cochrane Database Syst Rev 2005, Art. No.: CD002779.pub2. DOI:
21. Higgins JPT, Green S., eds. Cochrane reviewers handbook 5.1.0. Available at: (accessed on 22 May 2011).
22. Grushka M, Epstein J, Mott A. An open label, dose escalation pilot study of the effect of clonazepam in BMS. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 86(5): 557-61.
23. Albuquerque RJC, de Leeuw R, Carlson CR, Okeson JP, Miller CS, Andersen AH. Cerebral activation during thermal stimulation of patients who have burning mouth disorders: an fMRI study. Pain 2006; 122: 223-34.
24. Collins SL, Moore RA, Mcquay HJ. The visual analogue pain intensity scale: what is moderate pain in millimeters? Pain 1997; 72: 95-7.
25. Forssell H, Jääskeläinen S, Tenovuo O, Hinkka S. Sensory dysfunction in burning mouth syndrome. Pain 2002; 99: 41-7.
26. Femiano F, Gombos F, Scully C, Busciolano M, De Luca P. Burning mouth syndrome (BMS): controlled open trial of the efficacy of alpha-lipoic acid (thioctic acid) on symptomatology. Oral Dis 2000; 6: 274-7.
27. Femiano F, Gombos F, Scully C. Síndrome de boca ardiente. Estudio de la psicoterapia, medicación con ácido alfa- lipoico y combinación de terapias. Med Oral 2004; 9: 8-13.
28. Lee Y-S, Kho H-S, Kim Y-K, Chung S-C. Influence of topical capsaicin on facial sensitivity in response to experimental pain. J Oral Rehabil 2007; 34: 9-14.